Live Breaking News & Updates on Oregon Medical Research Center

Stay updated with breaking news from Oregon medical research center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Early Improvement in Prurigo Nodularis With IL-31 Antagonist Maintained at 1 Year

Itch, sleep disturbance, lesion healing, quality of life improved substantially in most patients ....

United States , Shawng Kwatra , Andrew Blauvelt , Charles Bankhead , Oregon Medical Research Center , Johns Hopkins Itch Center , American Academy Of Dermatology , American Academy , Investigator Global Assessment , Dermatology Life Quality Index , Peak Pruritus Numerical Rating Scale , Medpage Today ,

Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA

Blauvelt discusses the future research of higher-dose risankizumab for patients with psoriasis and why it may be "disruptive in the treatment space." ....

United States , San Diego , Andrew Blauvelt , American Academy Of Dermatology , Oregon Medical Research Center , American Academy , Aad 2024 , Sandy Blauvelt ,

Rizankizumab and the KNOCKOUT Study, with Andrew Blauvelt, MD, MBA

Blauvelt discusses the impetus for his phase 2 trial looking at the ability to mitigate pivotal psoriasis memory T cells with risankizumab. ....

San Diego , United States , Andrew Blauvelt , American Academy Of Dermatology , Oregon Medical Research Center , American Academy , Psoriasis Area Severity Index , Aad 2024 , Sandy Blauvelt ,

Are High Doses of Skyrizi a Cure for Plaque Psoriasis?

A "hit-it-hard, hit-it-early" strategy might eventually cure plaque psoriasis, says the researcher conducting a small study of high-dose Skyrizi that has produced promising results. Even so, the disease is not vanquished and "trickles back." ....

United States , San Diego , Andrew Blauvelt , Oregon Medical Research Center , American Academy Of Dermatology , American Academy , Psoriasis Area , Severity Scale ,

Home- and Office-Based Phototherapy for Psoriasis Compared

The multicenter LITE trial included 783 patients at 42 sites in the United States. ....

United States , University Of Pennsylvania , Andrew Blauvelt , Joelm Gelfand , Oregon Medical Research Center , Psoriasis Foundation , Improvement In Health Equity , Phototherapy Treatment Center At Penn , Henry Ford Health In Detroit , American Academy Of Dermatology , Global Assessment , Dermatology Life Quality Index , American Academy , Light Treatment Effectiveness , National Psoriasis Foundation , Henry Ford Health , Light Therapy , Plaque Psoriasis , Home Care , Domiciliary Care , Practice Management , Biologic Therapy , Social Determinants Of Health , Social Determinants Of Health Sdoh , Patient Safety , Guttate Psoriasis ,